Takeda Of Japan And Biological E. Of India Collaborate To Increase The Manufacture Of Dengue Vaccines
Through a collaboration with Indian vaccine manufacturer Biological E, Japan’s Takeda Pharmaceutical plans to increase production of its dengue vaccine Qdenga, the firms announced on Tuesday. By 2030, governments in endemic countries will have access to these dosages for use in their national immunisation efforts. According to the firms, Biological E. will increase its production…









